Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDT
1826
Chatham Lodging
CLDT
$625M
| $1.96M | ﹤0.01% |
141,902
+76,702
| +118% | +$1.05M |
|
|
LDTC
1827
DELISTED
LeddarTech
LDTC
| $1.96M | ﹤0.01% |
+398,736
| New | +$1.95M |
|
1828
Invesco DB Commodity Index Tracking Fund
DBC
$1.64B
| $1.96M | ﹤0.01% |
75,042
-399,631
| -84% | -$9.5M |
|
1829
NMI Holdings
NMIH
$3.38B
| $1.95M | ﹤0.01% |
94,583
-34,684
| -27% | -$810K |
|
|
IMAQ
1830
DELISTED
International Media Acquisition Corp. Class A Common Stock
IMAQ
| $1.95M | ﹤0.01% |
+196,952
| New | +$1.94M |
|
1831
Alamo Group
ALG
$2.04B
| $1.95M | ﹤0.01% |
13,568
-1,989
| -13% | -$288K |
|
1832
Gentherm
THRM
$1.28B
| $1.94M | ﹤0.01% |
26,611
-16,821
| -39% | -$1.4M |
|
|
MBSC
1833
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
| $1.94M | ﹤0.01% |
+195,218
| New | +$1.94M |
|
|
BRKL
1834
DELISTED
Brookline Bancorp
BRKL
| $1.94M | ﹤0.01% |
122,838
-29,862
| -20% | -$503K |
|
1835
Rackspace Technology
RXT
$1.21B
| $1.94M | ﹤0.01% |
+173,607
| New | +$2.05M |
|
1836
KBR
KBR
$4.58B
| $1.93M | ﹤0.01% |
35,350
-160,574
| -82% | -$7.8M |
|
|
ACR
1837
ACRES Commercial Realty
ACR
$104M
| $1.93M | ﹤0.01% |
+144,023
| New | +$1.77M |
|
1838
Hain Celestial
HAIN
$50.3M
| $1.93M | ﹤0.01% |
56,033
+12,227
| +28% | +$444K |
|
|
PICC
1839
DELISTED
Pivotal Investment Corporation III
PICC
| $1.93M | ﹤0.01% |
+196,794
| New | +$1.92M |
|
|
SRRA
1840
CALL
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.92M | ﹤0.01% |
+60,000
| New | +$1.72M |
|
|
WEL
1841
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $1.92M | ﹤0.01% |
+192,909
| New | +$1.91M |
|
1842
Agios Pharmaceuticals
AGIO
$1.89B
| $1.92M | ﹤0.01% |
65,880
-3,935
| -6% | -$120K |
|
1843
ACM Research
ACMR
$5.52B
| $1.91M | ﹤0.01% |
92,250
-21,414
| -19% | -$539K |
|
1844
City Holding Co
CHCO
$2.06B
| $1.91M | ﹤0.01% |
24,242
-5,125
| -17% | -$412K |
|
1845
AdvisorShares Pure US Cannabis ETF
MSOS
$812M
| $1.91M | ﹤0.01% |
+91,424
| New | +$1.99M |
|
1846
CALL
Incyte
INCY
$24.3B
| $1.91M | ﹤0.01% |
24,000
| – | – |
|
|
RODI
1847
DELISTED
iPath Return on Disability ETN
RODI
| $1.9M | ﹤0.01% |
16,500
| – | – |
|
|
CZOO
1848
DELISTED
Cazoo Group Ltd
CZOO
| $1.9M | ﹤0.01% |
+345
| New | +$2.63M |
|
1849
Celsius Holdings
CELH
$7.45B
| $1.9M | ﹤0.01% |
103,395
-115,536
| -53% | -$2.07M |
|
1850
Cirrus Logic
CRUS
$6.53B
| $1.89M | ﹤0.01% |
22,332
-12,821
| -36% | -$1.1M |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.